Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild‐type metastatic colorectal cancer treated with first‐line epidermal growth factor receptor monoclonal antibody

This meta‐analysis was performed to determine whether the addition of monoclonal antibodies (mAbs) of epidermal growth factor receptor (EGFR) to oxaliplatin‐based chemotherapy treatment improves efficacy in KRAS wild‐type metastatic colorectal cancer (mCRC), and whether infusional 5‐fluorouracil (5‐...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Autores principales: Wen, Feng, Tang, Ruilei, Sang, Yaxiong, Li, Meng, Hu, Qiancheng, Du, Zedong, Zhou, Yi, Zhang, Pengfei, He, Xiaofeng, Li, Qiu
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2013
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7656550/
https://ncbi.nlm.nih.gov/pubmed/23822592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12224
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares